ReviewCurrent psychiatry reports2025
Virtual Reality in the Treatment of Anxiety-Related Disorders: A Review of the Innovations, Challenges, and Clinical Implications.
Review in Current psychiatry reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Immersive virtual reality as an auxiliary intervention for college students with mild-to-moderate depressive symptoms: a pilot randomized controlled trial.Frontiers in psychology · 2026Trial
- Anticipation and prevention of real risks of virtual environments in psychiatry.NPJ digital medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purpose of reviewThis review aims to examine the evolving literature on virtual reality (VR) technology in the treatment of anxiety-related disorders. We explore recent evidence across categories of anxiety-related disorders, focusing on the advantages and limitations of VR as a means of delivering exposure therapy. Finally, we propose recommendations for incorporating VR in current clinical practice and areas for future innovation. RECENT
findingsVR-based exposure therapy (VRET) is the dominant application of VR for anxiety-related disorders. Growing evidence shows that it is a well-accepted intervention that is superior to waitlist conditions, especially for phobias, social anxiety, and post-traumatic stress disorder; however, more investigation is needed into how VRET compares to conventional treatment modalities. Recent innovations include successful self-directed VRET programs, augmenting VRET with neuromodulation, and beginning exploration of therapeutic processes in the delivery of VRET. Notable limitations include limited comparison to standard treatment and lack of standardization of VRET protocol, which limits translatability. VRET shows promise in enhancing treatment models for anxiety-related disorders, but uniformization of software and delivery protocols will be a key next step.
Indexed as
Identifiers
40679554What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.